Search:

Biotechnology Headlines from PR Newswire


< Go Back

Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C.
BioClinica to Present at 20th Annual SCDM Conference
ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging
SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States
AFAI Signs Joint Venture Agreement With Jatro Greentech Inc.
Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria
CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies
Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board
PTC Therapeutics Expands Global Presence in Support of Translarna™ Launch in Duchenne Muscular Dystrophy
Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates
Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer
Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin
RXi Pharmaceuticals Strengthens Intellectual Property Portfolio
Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma
Cardiorentis Announces Euro 45 Million Financing with HealthCare Royalty Partners to Fund Ularitide Registration Program in Acute Heart Failure
MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development
Global Bioinformatics Industry
3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China
Biocom Recognizes National Health IT Week
Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Global Digital Radiography Industry
Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer
Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting
New Appointment to the Scientific Advisory Committee at Egenix, Inc.
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day
Global Medicines for Russia
CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector
DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial
Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR
2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication
HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control
Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency
ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture
SeraCare Life Sciences Unveils Nets for Kids Program
LABSCO Secures Alliance With Siemens Healthcare Diagnostics
Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM)
Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe Spanish
Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER
EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema
Three new silver hydrogel wound-dressing products English English
Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease
InSightec Announces Closing of Investment Agreement and Extension of Investment Period to Accelerate Market Development of MR-Guided Focused Ultrasound Noninvasive Treatments
Sphere Fluidics Selects Cambridge Consultants as Product Engineering Partner for Cyto-Mine™ Development
STEM-Pharma® to Attend the 5th Innovation Days and Emerging Market Access Conference in Paris

< Prev Next >
PR Newswire - United Business Media